A B S T R A C T
The neuron navigator 2 (NAV2) gene is highly expressed in brain and involved in the nervous system development and may play a role in Alzheimer's disease (AD). We aimed to investigate the associations of 317 singlenucleotide polymorphisms (SNPs) in the NAV2 gene with the risk and age at onset (AAO) of AD using a familybased sample (1266 AD cases and 1279 healthy relatives). Association with the risk of AD was assessed using family-based association test -generalized estimating equations (FBAT-GEE) statistics while the association with AAO as a quantitative trait was evaluated using the FBAT-Wilcoxon statistic. Single marker analysis showed that 20 SNPs were significantly associated with the risk of AD (top SNP rs7112354 with p = 8.46 × 10 − 4 ) and 11
SNPs were associated with AAO (top SNP rs1354269 with p = 2.87 × 10 − 3
). Interestingly, two SNPs rs17614100 and rs12364788 were associated with both the risk (p = 1.7 × 10 − 2 and 2.71 × 10
; respectively) and AAO (p = 1.85 × 10 − 3 and 6.06 × 10
; respectively). Haplotype analyses further supported the results of single marker analyses. In addition, functional analysis showed that NAV2 mRNA had significant expression across ten human brain regions examined and significantly correlated with APOE expression in four of ten regions. The present study is the first study providing evidence of several genetic variants within the NAV2 gene influencing the risk and AAO of AD.
Introduction
Alzheimer's disease (AD) is a chronic neurodegenerative disease and the prevalence dramatically increases when people getting older than 65 years (Hebert et al., 2003) . It has been reported that AD is one of the top 10 leading causes of death in the United States (US) (Xu et al., 2010) . In 2013, approximately 5 million people in the US aged 65 years or older were living with AD, and this number is projected to rise to 13.8 million, a nearly three-fold increase, by 2050 (Hebert et al., 2013 . World Health Organization have reported that 0.379% of people worldwide had dementia in 2005 and the prevalence would increase to 0.441% in 2015 and to 0.556% in 2030 (WHO, 2006) . Family and twin studies have shown that the heritability of the risk of AD ranges from 49% to 79% (Gatz et al., 2006) . In addition to the disease risk, age-atonset (AAO) of AD is also genetically influenced with an estimated heritability of about 42% (Daw et al., 2000; Li et al., 2002) .
The neuron navigator 2 (NAV2) (also known as HELAD1; RAINB1; POMFIL2; UNC53H2; STEERIN2) gene is located at 11p15.1 (Coy et al., 2002; Maes et al., 2002) and contains 50 distinct GT/AG introns and 38 exons (Merrill et al., 2002) . The NAV2 gene was most highly expressed in brain and also in kidney, liver, thyroid, mammary gland, and spinal cord (Coy et al., 2002; Maes et al., 2002; Merrill et al., 2002) and may play a role in cellular growth, migration, and nervous system development (Coy et al., 2002; , Ishiguro et al., 2002; Merrill et al., 2002; Peeters et al., 2004; Clagett-Dame et al., 2006; McNeill et al., 2010; Marzinke et al., 2013) . Recently, NAV2 was found to be associated with episodic memory scores in AD (Yan et al., 2015) . However, no study has focused on the association of NAV2 gene with the risk or AAO of AD to date. Based on previous reports on the functions of NAV2 in nervous system development and its role in episodic memory scores in AD, we hypothesized that NAV2 gene polymorphisms might play a role in AD. We investigated the associations of 317 single-nucleotide polymorphisms (SNPs) in the NAV2 gene with the risk and AAO of AD using a family-based sample. 
